Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...
WHNT-TV Huntsville on MSN16d
ADPH Investigating Injection Reactions | Jan. 22, 2025 | News 19 at 5 p.m.In the news release, ADPH said it is working with the Center for Disease Control's Division of Healthcare Quality Promotion to investigate 11 reports of people experiencing "adverse events" following ...
Asian News International on MSN7h
Akums Drugs and Pharmaceuticals announces robust Q3 FY 25 results with 12% Adj EBITDA and 15% Adj PAT growthAkums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, 2024, delivering 12% increase in Adjusted EBITDA on year-on-year basis. Key ...
Many authors have suggested using a cephalosporin as an alternative to penicillin. Casey and Pichichero performed a meta-analysis of 35 randomized, controlled trials comparing penicillin with ...
17don MSN
The Alabama Department of Public Health issued a statement about its current investigation into certain "adverse events" following an injection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback